ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Pathological roles of lipid metabolism disorders in asthma and related intervention strategies].
Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Asthma is a heterogeneous chronic respiratory disease characterized by airflow obstruction, smooth muscle contraction, and excessive mucus secretion. In recent years, with the increasing prevalence of obesity-associated asthma and advances in technologies such as lipidomics, the central role of lipid metabolism disorders in the pathophysiology of asthma has attracted growing attention. Through regulating energy conversion, inflammatory signal transduction, and the generation of lipid mediators (such as leukotrienes and prostaglandins), lipid metabolism plays a critical role in the pathogenesis of asthma, including inflammatory responses, airway hyperresponsiveness, and airway remodeling. Targeting lipid metabolism has become an important strategy for drug development and has been proven effective. However, no single therapy is currently effective for all patients with asthma. Evaluation of the metabolic status of asthma patients may contribute to more precise phenotyping, while management of lipid nutrition and lifestyle may provide preventive protection for asthma patients. Examining asthma from the perspective of lipid metabolism may provide new theoretical foundations and practical directions for precision therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.